A Nature Medicine paper landed on Feb. 2 like a stone in a pond, sending out ripples that quickly turned into tidal waves across biomedical circles. By midday, renowned physician-scientist Eric Topol, ...
A study commissioned by President Joe Biden's administration to investigate alcohol-related health harms was released independently on Tuesday, after President Donald Trump's administration decided ...
(UroToday.com) The 2026 American Society of Clinical Oncology (ASCO) Annual Meeting was host to a kidney and bladder cancer oral abstract session. Dr. Gopa Iyer presented the initial results from ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Lung cancer is among the conditions that may be affected. GLP-1 medications such as Wegovy, ...
GLP-1 drugs may be linked to a lower risk of cancer progression, according to new research that will be presented next week at the American Society of Clinical Oncology’s annual meeting. Subscribe to ...
Are GLP-1 weight loss drugs like Ozempic the miracle many have waited for, or are used guinea pigs in an experiment they’ll regret in a decade? That’s the central question of a discussion Wednesday on ...
GLP‑1 drugs may fight addiction across every major substance, according to a study of 600,000 people
A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes. He didn’t use a patch. He ...
In a recent review, a small group of patients received the injections less frequently but still maintained weight loss and health benefits. By Roni Caryn Rabin See more of our coverage in your search ...
A commentary by FDA officials Vinay Prasad, MD, MPH, and Martin Makary, MD, MPH, details the new system for drug approvals in the US. FDA Commissioner Martin Makary, MD, MPH, and his top deputy Vinay ...
SALT LAKE CITY--(BUSINESS WIRE)--iVeena Delivery Systems, Inc. (“iVeena”), a clinical-stage ophthalmology company developing novel pharmacologic therapies for refractive eye diseases, today announced ...
-- Company to host a live webcast event with an expert panel of clinicians during ASH -- REDWOOD CITY, Calif.--(BUSINESS WIRE)--Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results